SG
KALA icon

StoneX Group’s KALA BIO KALA Stock Holding History

StoneX Group’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.25K Buy
260
+15
+6% +$317 ﹤0.01% 902
2025
Q4 		$6.81K Buy
+245
New +$11K ﹤0.01% 1017
2022
Q4 		– Sell
-5
Closed -$2.98K – 616
2022
Q3 		$2.98K Buy
+5
New +$3.93K ﹤0.01% 329

Other funds holding KALA

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

StoneX Group's KALA Position: Q1 2026 in Review

StoneX Group increased its KALA BIO (KALA) stake by 6.1% in Q1 2026, buying an estimated $317 and bringing the position to 260 shares worth $2.25K. The position accounts for ﹤0.01% of the portfolio, ranked #902.

StoneX Group first reported a position in KALA in Q3 2022 and has held it in 3 quarters since. The position peaked at $6.81K in Q4 2025. 28 funds tracked by Wall St. Rank hold KALA as of Q1 2026.

  • StoneX Group held 260 shares of KALA BIO worth $2.25K as of Q1 2026.
  • StoneX Group bought 15 KALA BIO shares in Q1 2026, an estimated $317.
  • KALA BIO made up ﹤0.01% of StoneX Group's portfolio in Q1 2026, its #902 holding.
  • StoneX Group first reported a position in KALA BIO in Q3 2022 and has held it in 3 quarters since.
  • StoneX Group's KALA BIO position peaked at $6.81K in Q4 2025.
  • 28 funds tracked by Wall St. Rank held KALA BIO as of Q1 2026.

Based on StoneX Group's 13F filing for Q1 2026, filed 14 May 2026.